INVITRO ACTIVITY OF DIRITHROMYCIN (LY-237216) COMPARED WITH ACTIVITIES OF OTHER MACROLIDE ANTIBIOTICS

被引:19
作者
YU, KW
NEU, HC
机构
[1] COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,630 W 168TH ST,NEW YORK,NY 10032
[2] COLUMBIA UNIV COLL PHYS & SURG,DEPT PHARMACOL,NEW YORK,NY 10032
关键词
D O I
10.1128/AAC.34.9.1839
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Dirithromycin inhibited Streptococcus pyogenes, Streptococcus pneumoniae, and other hemolytic streptococci at concentrations of ≤ 0.03 to 0.12 μg/ml, with 90% inhibition at 0.12 μg/ml, which is comparable to results using erythromycin. Group A streptococci, listeriae, and enterococci resistant to erythromycin were resistant to dirithromycin. Erythromycin-susceptible staphylococci were inhibited by 0.5 μg/ml, but for erythromycin-resistant isolates MICs were ≥ 8 μg/ml. For Haemophilus influenzae, MICs were ≥ 8 μg/ml, tow- to fourfold greater than for erythromycin. The activity of dirithromycin against staphylococci and streptococci was not decreased by the addition of human serum.
引用
收藏
页码:1839 / 1842
页数:4
相关论文
共 10 条
[1]   INVITRO COMPARISON OF THE ACTIVITY OF RU-28965, A NEW MACROLIDE, WITH THAT OF ERYTHROMYCIN AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].
BARLAM, T ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (04) :529-531
[2]   ACTIVITY OF A-56268 COMPARED WITH THAT OF ERYTHROMYCIN AND OTHER ORAL-AGENTS AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].
CHIN, NX ;
NEU, NM ;
LABTHAVIKUL, P ;
SAHA, G ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (03) :463-466
[3]   SUSCEPTIBILITY OF CAMPYLOBACTER-JEJUNI AND CAMPYLOBACTER-COLI TO MACROLIDES AND RELATED-COMPOUNDS [J].
ELHARRIF, Z ;
MEGRAUD, F ;
MARCHAND, AM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) :695-697
[4]   COMPARATIVE INVITRO ACTIVITIES OF NEW 14-MEMBERED, 15-MEMBERED, AND 16-MEMBERED MACROLIDES [J].
HARDY, DJ ;
HENSEY, DM ;
BEYER, JM ;
VOJTKO, C ;
MCDONALD, EJ ;
FERNANDES, PB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1710-1719
[5]   NEW DIRECTIONS FOR MACROLIDE ANTIBIOTICS - STRUCTURAL MODIFICATIONS AND INVITRO ACTIVITY [J].
KIRST, HA ;
SIDES, GD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1413-1418
[6]   NEW DIRECTIONS FOR MACROLIDE ANTIBIOTICS - PHARMACOKINETICS AND CLINICAL EFFICACY [J].
KIRST, HA ;
SIDES, GD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) :1419-1422
[7]   METHOD FOR RELIABLE DETERMINATION OF MINIMAL LETHAL ANTIBIOTIC CONCENTRATIONS [J].
PEARSON, RD ;
STEIGBIGEL, RT ;
DAVIS, HT ;
CHAPMAN, SW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (05) :699-708
[8]   ERYTHROMYCIN - A MICROBIAL AND CLINICAL PERSPECTIVE AFTER 30 YEARS OF CLINICAL USE .1. [J].
WASHINGTON, JA ;
WILSON, WR .
MAYO CLINIC PROCEEDINGS, 1985, 60 (03) :189-203
[9]   ERYTHROMYCIN - A MICROBIAL AND CLINICAL PERSPECTIVE AFTER 30 YEARS OF CLINICAL USE .2. [J].
WASHINGTON, JA ;
WILSON, WR .
MAYO CLINIC PROCEEDINGS, 1985, 60 (04) :271-278
[10]  
1988, M7T2 NAT COMM CLIN L